A Lassa fever vaccine candidate shows promise in animal studies, with guinea pigs 100 percent protected from lethal virus exposure.

How precision analytics is driving the future of pharmaceuticals, from small molecules to CRISPR gene editing.

How do you design, refine, and optimize novel GLP-1 drugs that could improve patient experiences? With a computer, of course.

A regulatory science push in the UK includes centres for digital transformation, AI and more.

The Access to Medicine Foundation has developed the 2026 AMR Benchmark to recognize and promote urgency in the ongoing AMR challenge.

Robert F Kennedy Jr’s recent speech suggests that investigations into childhood vaccines and over-medication could be on the cards.

Not all patients are able to reap the benefits of groundbreaking new therapeutics. The industry must do more.

Oral solid dosage, HPAPIs, OSD development, OSD formulations, poorly soluble drugs, fixed-dose combinations, controlled release

From gene therapy to novel excipients to trends in leadership and more. Check out some of our most popular videos.